Mira Pharmaceuticals Cash Flow Statement (2022-2025) | MIRA

Cash Flow Statement Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Share-based Compensation (Quarter) 0.15M0.15M0.15M0.74M1.45M0.21M0.50M0.60M0.27M0.55M0.87M0.53M0.12M4.30M
Gains from Sales and Divestitures (Quarter) 0.25M0.50M0.56M0.62M
Gains from Investment Securities (Quarter) 0.75M0.98M0.64M1.22M0.72M0.43M0.55M4.24M0.03M4.20M0.07M0.10M
Non-cash Items (Quarter) 0.14M2.70M3.99M3.40M6.02M
Cash from Operations (Quarter) -1.31M-0.98M-1.08M-0.66M-1.76M-1.04M-1.05M-0.86M-1.84M-1.81M-1.60M-0.80M-1.13M-1.17M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter) 0.44M
Change in Working Capital
Change in Receivables (Quarter) -0.01M
Change in Accured Expenses (Quarter) 0.35M0.17M0.18M-0.45M0.12M-0.24M0.10M0.15M-0.09M0.03M-0.62M0.19M-0.21M0.05M
Other Working Capital Changes (Quarter) 0.00M0.06M-0.02M0.16M0.04M-0.06M-0.08M-0.02M-0.03M0.10M-0.06M0.37M-0.03M
Financing Activities
Other financing activities (Quarter) 0.00M0.05M0.16M-0.35M0.11M0.16M
Cash from Financing Activities (Quarter) 0.68M1.14M0.73M0.68M7.60M-0.23M-0.02M0.16M3.16M0.49M0.00M0.32M3.01M4.84M
Dividend Payments
Dividends Paid - Common (Quarter) 0.02M-0.01M
Additional items
Change in Cash (Quarter) -0.64M0.16M-0.35M0.02M5.84M-1.27M-1.07M-0.70M1.32M-1.31M-1.63M-0.48M1.91M3.71M
Free Cash Flow (Quarter) -1.31M-0.98M-1.08M-0.66M-1.76M-1.04M-1.05M-0.86M-1.84M-1.81M-1.60M-0.80M-1.13M-1.17M
Net Cash Flow (Quarter) -0.64M0.16M-0.35M0.02M5.84M-1.27M-1.07M-0.70M1.32M-1.31M-1.60M-0.48M1.88M3.67M